ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 292 filers reported holding ICU MED INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,906,585 | -64.3% | 49,631 | -46.5% | 0.07% | -64.8% |
Q2 2023 | $16,524,450 | +45.6% | 92,735 | +34.8% | 0.20% | +27.3% |
Q1 2023 | $11,346,279 | -27.7% | 68,782 | -31.0% | 0.15% | -26.7% |
Q4 2022 | $15,695,874 | +27.7% | 99,669 | +22.1% | 0.21% | +22.1% |
Q3 2022 | $12,291,000 | +926.8% | 81,613 | +1021.1% | 0.17% | +855.6% |
Q2 2022 | $1,197,000 | -88.1% | 7,280 | -84.0% | 0.02% | -89.0% |
Q1 2022 | $10,101,000 | -62.7% | 45,367 | -60.2% | 0.16% | -57.7% |
Q4 2021 | $27,084,000 | +64.4% | 114,115 | +61.6% | 0.39% | +44.2% |
Q3 2021 | $16,479,000 | +73.4% | 70,611 | +52.9% | 0.27% | +52.0% |
Q2 2021 | $9,506,000 | -41.0% | 46,192 | -41.1% | 0.18% | -50.6% |
Q1 2021 | $16,122,000 | +8.5% | 78,475 | +13.3% | 0.36% | -9.1% |
Q4 2020 | $14,855,000 | -11.9% | 69,259 | -24.9% | 0.39% | -28.8% |
Q3 2020 | $16,862,000 | -28.4% | 92,263 | -27.8% | 0.55% | -40.7% |
Q2 2020 | $23,541,000 | +101.5% | 127,725 | +120.6% | 0.93% | +11.7% |
Q1 2020 | $11,683,000 | -0.2% | 57,903 | -7.5% | 0.84% | +74.7% |
Q4 2019 | $11,708,000 | – | 62,571 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVR Research LP | 22,000 | $4,719,000 | 3.86% |
NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |